# Armata Pharmaceuticals (ARMP) — Earnings

ARMP · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/armp/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.45 |
| EPS estimate | −$0.39 |
| EPS surprise | −15.38% |
| Revenue surprise | +57.17% |
| Revenue | $2.2M |
| Revenue estimate | $1.4M |
| Reported | Aug 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/921114/000155837025011235/armp-20250630x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 12, 2025 | −$0.39 | −$0.45 | -15.38% | $1.4M | $2.2M |
| Q1 2025 | May 14, 2025 | −$0.38 | −$0.20 | 47.37% | $1.4M | $491,000.00 |
| Q4 2024 | Mar 21, 2025 | −$0.35 | −$0.23 | 34.29% | $1.6M | $1.2M |
| Q3 2024 | Nov 13, 2024 | −$0.28 | −$0.15 | 46.43% | $900,000.00 | $3.0M |
| Q2 2024 | Aug 13, 2024 | −$0.37 | −$0.25 | 32.43% | $1.1M | — |
| Q1 2024 | May 7, 2024 | −$0.31 | −$0.69 | -122.58% | $1.1M | $966,000.00 |
| Q4 2023 | Mar 21, 2024 | −$0.29 | −$0.55 | -92.98% | $840,000.00 | $1.5M |
| Q3 2023 | Nov 14, 2023 | −$0.26 | −$0.86 | -237.25% | $950,000.00 | $1.2M |
| Q2 2023 | Aug 14, 2023 | −$0.30 | −$0.17 | 42.37% | $1.8M | $980,000.00 |
| Q1 2023 | May 11, 2023 | −$0.25 | −$0.40 | -60.00% | $1.8M | $796,000.00 |
| Q4 2022 | Mar 16, 2023 | −$0.22 | −$0.29 | -34.88% | $1.7M | $1.1M |
| Q3 2022 | Nov 9, 2022 | −$0.22 | −$0.24 | -9.09% | $1.6M | $1.3M |
| Q2 2022 | Aug 11, 2022 | −$0.19 | −$0.26 | -36.84% | $1.1M | $1.9M |
| Q1 2022 | May 12, 2022 | −$0.17 | −$0.30 | -81.82% | $975,000.00 | $1.2M |
| Q4 2021 | Mar 17, 2022 | −$0.24 | −$0.23 | 4.17% | $775,000.00 | $989,000.00 |
| Q3 2021 | Nov 10, 2021 | −$0.23 | −$0.22 | 5.70% | $1.1M | $1.3M |
| Q2 2021 | Aug 12, 2021 | −$0.21 | −$0.25 | -21.95% | $410,000.00 | $1.2M |
| Q1 2021 | May 13, 2021 | −$0.24 | −$0.27 | -14.89% | — | $1.1M |
| Q4 2020 | Mar 18, 2021 | −$0.10 | −$0.36 | -269.23% | $270,667.00 | $504,000.00 |
| Q3 2020 | Nov 12, 2020 | −$0.20 | −$0.31 | -52.48% | $875,000.00 | $288,000.00 |

## Frequently Asked Questions

### When did Armata Pharmaceuticals (ARMP) last report earnings?

Armata Pharmaceuticals last reported on Aug 12, 2025, covering fiscal Q2 2025.

### Did ARMP beat earnings estimates?

No. Armata Pharmaceuticals reported EPS of −$0.45 for Q2 2025 against a −$0.39 estimate — a 15.38% miss.

### How much revenue did ARMP report last quarter?

Armata Pharmaceuticals reported $2.2M in revenue for Q2 2025, against a consensus estimate of $1.4M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).